About your Search

20090801
20090831
Search Results 0 to 3 of about 4 (some duplicates have been removed)
to help treat osteoporosis with once-a-month actonel. actonel is clinically proven to help reverse bone loss and can help increase bone strength to help prevent fractures. so you can get back some of what you lost. do not take actonel if you have low blood calcium, severe kidney disease, or cannot sit or stand for 30 minutes. follow all dosing instructions. stop taking actonel and tell your doctor if you experience difficult or painful swallowing, chest pain or severe or continuing heartburn. these may be signs of serious upper digestive problems. promptly tell your doctor if you develop severe bone, joint or muscle pain, or if you develop dental problems, as serious jawbone problems have been reported rarely. the more you know about osteoporosis, the more you'll want to ask your doctor if once-a-month actonel is right for you. (announcer) if you can't afford your medication, visit actonel.com to find out how the alliance for er wttbe bone health may be able to help. a tornado hits, air life denver takes off... their night-vision goggles keeping the rescue mission safe... and powering t
makes escription drugs ke actonel for bone loss and asacol for digesti disorders. ose drugs generate $2.3 billion in annl sales, adding out $540 million in profits p-and-g's bottomine. warner chilcott expects to kp most othe p-and-g pharceutical employees, the deal's expected to clo by the end of t year. innother acquisition, charlotte russe is bei taken private by advent inrnational. the private equity firm is paying $380 millioor $17.50 a share for the mall-basedeller of young womens clotng. the offer is a 27% premium t friday's closingrice. charlotte russe has 500 stes in the u.s. and puerto rico st year it's saletopped $823 milln. >> paul: susie, e company began exploring itoptions in january asales slumped and put itself on the marketn march. we'll see its we take a look our stocks in the news tonight. and those are the stocks in e news tonight, sie. >> susieit's the end of the road for the government's sh for clunkers pgram. the $3-bilon rebate plan ends tonight, for consumers. but late today, dealships were givenn extension. they now havuntil noon tomorrow to submit their paperwo
.1 billion. that unit makes prescription drugs like actonel for bone loss and asacol for digestive disorders. those drugs generate $2.3 billion in annual sales, adding about $540 million in profits to p-and-g's bottom line. warner chilcott expects to keep most of the p-and-g pharmaceutical employees, the deal's expected to close by the end of the year. in another acquisition, charlotte russe is being taken private by advent international. the private equity firm is paying $380 million or $17.50 a share for the mall-based seller of young womens clothing. the offer is a 27% premium to friday's closing price. charlotte russe has 500 stores in the u.s. and puerto rico last year it's sales topped $823 million. >> paul: susie, the company began exploring its options in january as sales slumped and put itself on the market in march. we'll see it as we take a look at our stocks in the news tonight. and those are the stocks in the news tonight, susie. >> susie: it's the end of the road for the government's cash for clunkers program. the $3-billion rebate plan ends tonight, for consumers. but late tod
Search Results 0 to 3 of about 4 (some duplicates have been removed)